Treatment Action Group and global partners will host a webinar on 3 October 2017, at 8:30 am ET, on urging policymakers and funders to procure and implement the TB LAM test.
The TB LAM test represents the only current point-of-care TB diagnostic test overall, that is specifically used for detecting TB in HIV-positive people with low CD4 counts, and is the only test that has a proven impact on reducing TB deaths in people with HIV.
Khairunisa Suleiman will moderate, with speakers including Lynette Mabote (AIDS & Rights Alliance for Southern Africa), Stephen Wanjala (Médecins Sans Frontières), and Wayne van Gemert (Global Drug Facility).
To register, click here.
Source: Treatment Action Group